Tag: Albert Bourla

Why India did not allow Pfizer’s Covid-19 vaccine

Tina Marie (Ms. Cat)

Why India did not allow Pfizer’s Covid-19 vaccine

In Latin America pharmaceutical bullying went a notch higher. In addition to legal indemnity, Pfizer demanded protection against their own negligence and mistakes. Argentina amended its vaccine law, three times, yet Pfizer was not happy. Pfizer wanted Argentina’s bank reserves and military bases as “guarantees”.

In the era of neo-colonialism, Pharma industry was the new East India Company.

…

Despite such pressure, India did not succumb. Eventually, Pfizer withdrew its application in 2021 We continued our vaccine programme with drugs that complied with our legal requirements.

UPDATED: FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

Tina Marie (Ms. Cat)

FDA is considering FOURTH dose of COVID-19 vaccine and making it an annual shot as cases across the US drop 43% over the past week and 87% since the peak of the Omicron variant

Related:

WSJ: FDA Eyes Second Covid-19 Booster Shot

A fourth booster shot of either the Pfizer or Moderna vaccine could start an annual booster shot campaign, one of the people familiar with the FDA’s planning said.

I’m not buying the media’s scaremongering about the second omicron variant!

The FDA just fully approved Pfizer’s COVID-19 vaccine in a move that could lead to more vaccinations

Tina Marie (Ms. Cat)1 Comment

The FDA just fully approved Pfizer’s COVID-19 vaccine in a move that could lead to more vaccinations

The shift to full approval could persuade some vaccine-hesitant people in the US to get the shot. A common talking point among skeptics of the COVID-19 shots has been that they’re not fully approved and are technically experimental medicines under emergency OKs. Pfizer’s vaccine winning standard approval directly addresses that concern.

No, it won’t, because they were fast-tracked! All they care about are profits!

He said the fast-track decision appeared more political than scientific since it skipped the usual formal advisory committee meeting and did not fully account for the reports of deaths and disabilities suffered by people after being vaccinated.

Senator Ron Johnson

Pfizer CEO to Public: Just ‘Trust’ Us on the Covid Booster

Tina Marie (Ms. Cat)

Pfizer CEO to Public: Just Trust Us on the Covid Booster

Pfizer announced its global phase 3 trial on a third dose in mid-July. That trial’s completion date is in 2022. Phase 3 results generally are required before regulatory approval.

“We are confident in this vaccine and the third dose, but you have to remember the vaccine efficacy study is still going on, so we need all the evidence to back up that,” Jerica Pitts, Pfizer’s director of global media relations, said Monday. The financial stakes are enormous: Pfizer announced in July that it expects $33.5 billion in covid-19 vaccine revenue this year.

…

The White House has added to the mixed messaging: Spokesperson Jen Psaki confirmed that the U.S. will buy an additional 200 million doses of the Pfizer-BioNTech vaccine for inoculating children under 12 and for possible boosters.